Clinical Trials
3 trialsNCT04105374 2026-05-07
Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma
NRG Oncology
Phase 2/3 Withdrawn
NCT04053114 2025-08-29
MOLTHYSO
Institut Bergonié
Withdrawn
NCT02211027 2017-09-07
Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA
University of Pittsburgh
Phase 1 Withdrawn